Glaucoma

VSP Vision has launched AARP Vision Plans from VSP, which includes a number of vision and eye wear insurance options tailored to the needs of AARP members.

January is National Glaucoma Awareness Month, a time to spread awareness about a disease that accounts for 9% to 12% of all cases of blindness in the U.S., according to the Glaucoma Research Foundation.

Throughout the year, Healio publishes a host of blogs on topics ranging from common conditions like keratoconus and glaucoma to crossover care that includes concussion management and diseases of the brain.

Therapies for treating glaucoma, including doxycycline and blue-light filtering IOLs, made top headlines this year in optometry news.

The self-measurement iCare Home2 tonometer may be reliable for most eyes and clinical settings, although central corneal thickness measurements are recommended before use, according to research published in the Journal of Glaucoma.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Renee Bovelle, MD, discusses real-world insights on the use of Dextenza.

Patients with open-angle glaucoma who abstain from consuming alcohol may be at lower risk for severe visual impairment and blindness, according to a review published in JAMA Network Open.

Skye Bioscience has treated the first patient in its phase 2 study of SBI-100 ophthalmic emulsion, a CB1 agonist delivered as an eye drop to treat patients with elevated IOP, according to a company press release.

Factors including IOP, anterior chamber depth, cataract and short-term antidepressant exposure may increase primary angle-closure glaucoma risk, according to a review published in Optometry and Vision Science.